Spencer K Michalke, MD - Medicare Plastic And Reconstructive Surgery in Phoenix, AZ

Spencer K Michalke, MD is a medicare enrolled "Plastic Surgery" physician in Phoenix, Arizona. He went to Wake Forest University School Of Medicine and graduated in 2012 and has 12 years of diverse experience with area of expertise as Plastic And Reconstructive Surgery. He is a member of the group practice Regency Reconstruction Pllc and his current practice location is 10240 W Indian School Rd Ste 115, Phoenix, Arizona. You can reach out to his office (for appointments etc.) via phone at (623) 243-9077.

Spencer K Michalke is licensed to practice in Arizona (license number 62006) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1801155064.

Contact Information

Spencer K Michalke, MD
10240 W Indian School Rd Ste 115,
Phoenix, AZ 85037-5905
(623) 243-9077
Not Available



Physician's Profile

Full NameSpencer K Michalke
GenderMale
SpecialityPlastic And Reconstructive Surgery
Experience12 Years
Location10240 W Indian School Rd Ste 115, Phoenix, Arizona
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Spencer K Michalke attended and graduated from Wake Forest University School Of Medicine in 2012
  NPI Data:
  • NPI Number: 1801155064
  • Provider Enumeration Date: 05/09/2012
  • Last Update Date: 08/27/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0143645218
  • Enrollment ID: I20210127000976

Medical Identifiers

Medical identifiers for Spencer K Michalke such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1801155064NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208200000XPlastic Surgery 62006 (Arizona)Primary
2086S0122XSurgery - Plastic And Reconstructive Surgery MD470416 (Pennsylvania)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Scottsdale Osborn Medical CenterScottsdale, AZHospital
Honorhealth Deer Valley Medical CenterPhoenix, AZHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Regency Reconstruction Pllc40829689955

News Archive

Study shows utility of cfDNA blood tests for breast cancer patients

Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

Discovery Laboratories, Inc. is providing an expanded update regarding ongoing efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization for Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

New Spectrum digitizers are ideal for use in multi-channel applications

Spectrum Instrumentation has added twelve new products to its family of LXI-based digitizerNETBOX data acquisition instruments. Designed specifically for situations where multiple signals need to be acquired, stored and analyzed, users can select from models that provide 24, 32, 40 or even 48 fully synchronized channels.

Discovery of mechanism that protects somatic cells against the behaviour of germ cells

An IRB Barcelona research team discovers the mechanism that favors the correct separation of germ cells - future ovules and sperm - from the rest of the cells during embryonic development

New investments, innovative strategies needed to train health professionals for developing world

Noting "the WHO has estimated that there is a global shortage of more than four million trained health care workers," Robert Bollinger, professor of infectious diseases at the Johns Hopkins School of Medicine, writes in the Huffington Post "Impact" blog, "It is very clear that new and innovative strategies are needed to train the large number of health professionals needed for Africa, Asia, and Latin America."

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Spencer K Michalke allows following entities to bill medicare on his behalf.
Entity NameMussman Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1821539156
PECOS PAC ID: 7517237365
Enrollment ID: O20170726004124

News Archive

Study shows utility of cfDNA blood tests for breast cancer patients

Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

Discovery Laboratories, Inc. is providing an expanded update regarding ongoing efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization for Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

New Spectrum digitizers are ideal for use in multi-channel applications

Spectrum Instrumentation has added twelve new products to its family of LXI-based digitizerNETBOX data acquisition instruments. Designed specifically for situations where multiple signals need to be acquired, stored and analyzed, users can select from models that provide 24, 32, 40 or even 48 fully synchronized channels.

Discovery of mechanism that protects somatic cells against the behaviour of germ cells

An IRB Barcelona research team discovers the mechanism that favors the correct separation of germ cells - future ovules and sperm - from the rest of the cells during embryonic development

New investments, innovative strategies needed to train health professionals for developing world

Noting "the WHO has estimated that there is a global shortage of more than four million trained health care workers," Robert Bollinger, professor of infectious diseases at the Johns Hopkins School of Medicine, writes in the Huffington Post "Impact" blog, "It is very clear that new and innovative strategies are needed to train the large number of health professionals needed for Africa, Asia, and Latin America."

Read more Medical News

› Verified 7 days ago

Entity NameRegency Reconstruction Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972086924
PECOS PAC ID: 4082968995
Enrollment ID: O20181113000903

News Archive

Study shows utility of cfDNA blood tests for breast cancer patients

Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

Discovery Laboratories, Inc. is providing an expanded update regarding ongoing efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization for Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

New Spectrum digitizers are ideal for use in multi-channel applications

Spectrum Instrumentation has added twelve new products to its family of LXI-based digitizerNETBOX data acquisition instruments. Designed specifically for situations where multiple signals need to be acquired, stored and analyzed, users can select from models that provide 24, 32, 40 or even 48 fully synchronized channels.

Discovery of mechanism that protects somatic cells against the behaviour of germ cells

An IRB Barcelona research team discovers the mechanism that favors the correct separation of germ cells - future ovules and sperm - from the rest of the cells during embryonic development

New investments, innovative strategies needed to train health professionals for developing world

Noting "the WHO has estimated that there is a global shortage of more than four million trained health care workers," Robert Bollinger, professor of infectious diseases at the Johns Hopkins School of Medicine, writes in the Huffington Post "Impact" blog, "It is very clear that new and innovative strategies are needed to train the large number of health professionals needed for Africa, Asia, and Latin America."

Read more Medical News

› Verified 7 days ago

Entity NameRegency Ambulatory Surgery Center One Llc
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1073155834
PECOS PAC ID: 3072932235
Enrollment ID: O20201007003068

News Archive

Study shows utility of cfDNA blood tests for breast cancer patients

Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

Discovery Laboratories, Inc. is providing an expanded update regarding ongoing efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization for Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

New Spectrum digitizers are ideal for use in multi-channel applications

Spectrum Instrumentation has added twelve new products to its family of LXI-based digitizerNETBOX data acquisition instruments. Designed specifically for situations where multiple signals need to be acquired, stored and analyzed, users can select from models that provide 24, 32, 40 or even 48 fully synchronized channels.

Discovery of mechanism that protects somatic cells against the behaviour of germ cells

An IRB Barcelona research team discovers the mechanism that favors the correct separation of germ cells - future ovules and sperm - from the rest of the cells during embryonic development

New investments, innovative strategies needed to train health professionals for developing world

Noting "the WHO has estimated that there is a global shortage of more than four million trained health care workers," Robert Bollinger, professor of infectious diseases at the Johns Hopkins School of Medicine, writes in the Huffington Post "Impact" blog, "It is very clear that new and innovative strategies are needed to train the large number of health professionals needed for Africa, Asia, and Latin America."

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Spencer K Michalke is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Spencer K Michalke, MD
160 E Station Square Dr Apt 518,
Pittsburgh, PA 15219-1173

Ph: (336) 756-9350
Spencer K Michalke, MD
10240 W Indian School Rd Ste 115,
Phoenix, AZ 85037-5905

Ph: (623) 243-9077

News Archive

Study shows utility of cfDNA blood tests for breast cancer patients

Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

Discovery Laboratories, Inc. is providing an expanded update regarding ongoing efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization for Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

New Spectrum digitizers are ideal for use in multi-channel applications

Spectrum Instrumentation has added twelve new products to its family of LXI-based digitizerNETBOX data acquisition instruments. Designed specifically for situations where multiple signals need to be acquired, stored and analyzed, users can select from models that provide 24, 32, 40 or even 48 fully synchronized channels.

Discovery of mechanism that protects somatic cells against the behaviour of germ cells

An IRB Barcelona research team discovers the mechanism that favors the correct separation of germ cells - future ovules and sperm - from the rest of the cells during embryonic development

New investments, innovative strategies needed to train health professionals for developing world

Noting "the WHO has estimated that there is a global shortage of more than four million trained health care workers," Robert Bollinger, professor of infectious diseases at the Johns Hopkins School of Medicine, writes in the Huffington Post "Impact" blog, "It is very clear that new and innovative strategies are needed to train the large number of health professionals needed for Africa, Asia, and Latin America."

Read more News

› Verified 7 days ago


Plastic Surgery Doctors in Phoenix, AZ

Dr. Amelia Catherine Van Handel, M.D.
Plastic Surgery
Medicare: Medicare Enrolled
Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008
Phone: 410-999-0858    
Dr. Salvatore C Lettieri, M.D.
Plastic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054
Phone: 480-301-8000    
Dr. Anthony A Smith, M.D.
Plastic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054
Phone: 480-301-8000    
Tim Matatov, M.D.
Plastic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 2801 E Camelback Rd Ste 100, Phoenix, AZ 85016
Phone: 480-576-4310    Fax: 480-576-4311
Kathryn Sarah King, MD
Plastic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 1920 E Cambridge Ave, Phoenix, AZ 85006
Phone: 813-978-9700    Fax: 813-558-6185
Dr. Davinder J Singh, M.D.
Plastic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 1920 E Cambridge Ave Ste 201, Phoenix, AZ 85006
Phone: 602-933-0500    Fax: 602-933-4320
Nicole Marie Kurnik, MD
Plastic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 1920 E Cambridge Ave Ste 201, Phoenix, AZ 85006
Phone: 602-933-0500    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.